跳至主要内容
临床试验/NCT03334981
NCT03334981已完成不适用

Interest of Concentrations in Meconium of Drugs Used for Treatment of Pregnant Opioid-dependent Woman as a Prognostic Factor of Time, Severity and Duration of Neonatal Abstinence Syndrome

University Hospital, Caen1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2012年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
92
试验地点
1
主要终点
meconium concentration of buprenorphine

研究概览

简要总结

The aim of this study is to characterize the interest of concentrations in meconium of drugs used for treatment of pregnant opioid-dependent woman as a prognostic factor of time, severity and duration of neonatal abstinence syndrome (NAS). 43 women treated with buprenorphine, 49 with methadone, and their newborns, were included. NAS is assessed by Lipsitz scale. Buprenorphine, norbuprenorphine, methadone, EDDP and morphine are quantified in meconium (one collected immediately after birth, another for 24 to 48 h) by a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, developed and validated for this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Aged over 18 years
  • •pregnant women
  • •Having agreed to participate in the study after information
  • •Under opioid replacement therapy during pregnancy, in combination or not with other psychotropic drugs or legal or illegal substances.
  • •Delivery after more than 34 weeks of amenorrhea

排除标准

  • •Pregnant women not receiving substitution treatment (methadone or buprenorphine).
  • •Patient under substitution treatment delivering before 34 weeks of amenorrhea
  • •Patient aged under 18 yrs old
  • •Patient unable to understand the study (mental deficiency, impairment of consciousness, not French) or not accepting to answer the questionnaires.
  • •Severe malformation syndrome or chromosomal abnormality in newborn discovered during pregnancy.
  • •mother's death or newborn's death

结局指标

主要结局

meconium concentration of buprenorphine

时间窗: variation over time at baseline and 24hrs to 48hrs after birth

meconium concentration of methadone

时间窗: variation over time at baseline and 24hrs to 48hrs after birth

次要结局

  • urine concentration of buprenorphine or methadone(baseline and 24hrs to 48hrs after birth)
  • by the score of Lipsitz,(4 times a day when the newborn is awake from baseline to 48hrs)
  • screening of other drugs in mother's urine and meconium(baseline and 24hrs to 48hrs after birth)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验